| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.28 |
3e-11 |
| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
8e-10 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
9e-09 |
| mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
6e-08 |
| mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
2e-07 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.3 |
5e-07 |
| mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
6e-07 |
| mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
9e-07 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
7e-06 |